医疗保健政策。改革药品未贴标签宣传以加强罕见病治疗。 - Suppr

Health care policy. Reforming off-label promotion to enhance orphan disease treatment.

作者信息

Liang Bryan A, Mackey Tim

机构信息

Institute of Health Law Studies, California Western School of Law, San Diego, CA 92101, USA.

出版信息

Science. 2010 Jan 15;327(5963):273-4. doi: 10.1126/science.1181567.

DOI:10.1126/science.1181567

PMID:20075234

Abstract

摘要

相似文献

Health care policy. Reforming off-label promotion to enhance orphan disease treatment.

Science. 2010 Jan 15;327(5963):273-4. doi: 10.1126/science.1181567.

Rare diseases, orphan drugs, and orphaned patients.

Mol Interv. 2006 Aug;6(4):186-91. doi: 10.1124/mi.6.4.2.

Should off-label drug use be off-the-table?

J Pediatr Endocrinol Metab. 2007 Feb;20(2):171-2.

"Creating hope" and other incentives for drug development for children.

Sci Transl Med. 2011 Jan 19;3(66):66cm1. doi: 10.1126/scitranslmed.3001707.

Developing treatments for inborn errors: incentives available to the clinician.

Mol Genet Metab. 2004 Apr;81 Suppl 1:S63-6. doi: 10.1016/j.ymgme.2003.10.015.

Orphan drugs and orphan tests in the USA.

Community Genet. 2004;7(4):169-72. doi: 10.1159/000082255.

A cross-national comparative study of orphan drug policies in the United States, the European Union, and Japan: towards a made-in-China orphan drug policy.

J Public Health Policy. 2010 Dec;31(4):407-20; discussion 420-1. doi: 10.1057/jphp.2010.30.

Adopting orphan drugs--two dozen years of treating rare diseases.

N Engl J Med. 2006 Feb 2;354(5):445-7. doi: 10.1056/NEJMp058317.

The Minor Use and Minor Species Animal Health Act: past, present, and future.

Food Drug Law J. 2006;61(1):13-43.

The routes to orphan drug designation--our recent experience at the FDA.

Drug Discov Today. 2012 Feb;17(3-4):97-9. doi: 10.1016/j.drudis.2011.12.014. Epub 2011 Dec 22.

引用本文的文献

Literature Review on Health Emigration in Rare Diseases-A Machine Learning Perspective.

Int J Environ Res Public Health. 2023 Jan 30;20(3):2483. doi: 10.3390/ijerph20032483.

Utilization of biotechnological drugs in rare diseases requiring the use of off-label drugs in children in Turkey.

Turk J Med Sci. 2021 Aug 30;51(4):1791-1799. doi: 10.3906/sag-2012-355.

A multidisciplinary review of the policy, intellectual property rights, and international trade environment for access and affordability to essential cancer medications.

Global Health. 2019 Sep 18;15(1):57. doi: 10.1186/s12992-019-0497-3.

Innovation in neglected tropical disease drug discovery and development.

Infect Dis Poverty. 2018 Jun 18;7(1):67. doi: 10.1186/s40249-018-0444-1.

Off-label use of orphan medicinal products: a Belgian qualitative study.

Orphanet J Rare Dis. 2016 Oct 28;11(1):144. doi: 10.1186/s13023-016-0507-y.

Digital Direct-to-Consumer Advertising: A Perfect Storm of Rapid Evolution and Stagnant Regulation Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".

Int J Health Policy Manag. 2016 Feb 3;5(4):271-4. doi: 10.15171/ijhpm.2016.11.

Medication Repurposing in Pediatric Patients: Teaching Old Drugs New Tricks.

J Pediatr Pharmacol Ther. 2016 Jan-Feb;21(1):36-53. doi: 10.5863/1551-6776-21.1.36.

Going "social" to access experimental and potentially life-saving treatment: an assessment of the policy and online patient advocacy environment for expanded access.

BMC Med. 2016 Feb 2;14:17. doi: 10.1186/s12916-016-0568-8.

Value-based reimbursement decisions for orphan drugs: a scoping review and decision framework.

Pharmacoeconomics. 2015 Mar;33(3):255-69. doi: 10.1007/s40273-014-0235-x.

Pharmaceutical pricing, cost containment and new treatments for rare diseases in children.

Orphanet J Rare Dis. 2014 Oct 28;9:152. doi: 10.1186/s13023-014-0152-2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Health care policy. Reforming off-label promotion to enhance orphan disease treatment.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献